This article first appeared on GuruFocus.

GoodRx Holdings Inc (NASDAQ:GDRX) is set to release its Q3 2025 earnings on Nov 5, 2025. The consensus estimate for Q3 2025 revenue is $194.55 million, and the earnings are expected to come in at $0.03 per share. The full year 2025's revenue is expected to be $797.95 million and the earnings are expected to be $0.14 per share. More detailed estimate data can be found on the Forecast page.

Warning! GuruFocus has detected 4 Warning Signs with GDRX.

Is GDRX fairly valued? Test your thesis with our free DCF calculator.

Over the past 90 days, revenue estimates for GoodRx Holdings Inc (NASDAQ:GDRX) have declined from $820.18 million to $797.95 million for the full year 2025, and from $864.28 million to $840.23 million for 2026. Similarly, earnings estimates have decreased from $0.16 per share to $0.14 per share for 2025, and from $0.22 per share to $0.18 per share for 2026.

In the previous quarter ending June 30, 2025, GoodRx Holdings Inc's (NASDAQ:GDRX) actual revenue was $203.07 million, which missed analysts' revenue expectations of $205.89 million by -1.37%. GoodRx Holdings Inc's (NASDAQ:GDRX) actual earnings were $0.04 per share, which met analysts' earnings expectations. After releasing the results, GoodRx Holdings Inc (NASDAQ:GDRX) was down by -20.05% in one day.

Based on the one-year price targets offered by 13 analysts, the average target price for GoodRx Holdings Inc (NASDAQ:GDRX) is $5.34 with a high estimate of $7.00 and a low estimate of $3.40. The average target implies an upside of 61.28% from the current price of $3.31.

Based on GuruFocus estimates, the estimated GF Value for GoodRx Holdings Inc (NASDAQ:GDRX) in one year is $7.12, suggesting an upside of 115.11% from the current price of $3.31.

Based on the consensus recommendation from 15 brokerage firms, GoodRx Holdings Inc's (NASDAQ:GDRX) average brokerage recommendation is currently 2.3, indicating an \\"Outperform\\" status. The rating scale ranges from 1 to 5, where 1 signifies strong buy, and 5 denotes sell.